Shenglan Qi

479 total citations
29 papers, 345 citations indexed

About

Shenglan Qi is a scholar working on Molecular Biology, Pharmacology and Epidemiology. According to data from OpenAlex, Shenglan Qi has authored 29 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Pharmacology and 7 papers in Epidemiology. Recurrent topics in Shenglan Qi's work include Synthesis and bioactivity of alkaloids (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Liver Diseases and Immunity (4 papers). Shenglan Qi is often cited by papers focused on Synthesis and bioactivity of alkaloids (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Liver Diseases and Immunity (4 papers). Shenglan Qi collaborates with scholars based in China and United Kingdom. Shenglan Qi's co-authors include Changhong Wang, Xuemei Cheng, Wei Liu, Chao Ma, Huida Guan, Gang Deng, Qiyan Lin, Ping Liu, Yunpeng Zhang and Wenzheng Ding and has published in prestigious journals such as Carbohydrate Polymers, Journal of Ethnopharmacology and International Journal of Biological Macromolecules.

In The Last Decade

Shenglan Qi

25 papers receiving 338 citations

Peers

Shenglan Qi
Shenglan Qi
Citations per year, relative to Shenglan Qi Shenglan Qi (= 1×) peers Bùi Thanh Tùng

Countries citing papers authored by Shenglan Qi

Since Specialization
Citations

This map shows the geographic impact of Shenglan Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglan Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglan Qi more than expected).

Fields of papers citing papers by Shenglan Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglan Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglan Qi. The network helps show where Shenglan Qi may publish in the future.

Co-authorship network of co-authors of Shenglan Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglan Qi. A scholar is included among the top collaborators of Shenglan Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglan Qi. Shenglan Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Rong, Pu Wang, Shenglan Qi, et al.. (2025). Discovery and optimization of a novel non-nitrocatechol COMT inhibitor for modulating levodopa metabolism. Journal of Pharmaceutical Analysis. 101520–101520. 1 indexed citations
2.
Zhao, Bei, Yuan Xiong, Lin Chen, et al.. (2025). Yujie recipe attenuates bleomycin-induced pulmonary fibrosis via suppressing NF-κB/NLRP3 signaling in a Nrf2-dependent manner. Phytomedicine. 150. 157607–157607.
3.
Song, Yuqing, Feng Zhang, Yufan Fan, et al.. (2025). High-efficient discovering the potent anti-Notum agents from herbal medicines for combating glucocorticoid-induced osteoporosis. Acta Pharmaceutica Sinica B. 15(8). 4174–4192. 3 indexed citations
4.
Xiao, Zhun, et al.. (2025). Taohong Siwu Decoction modulates glutathione metabolism to suppress hepatocyte ferroptosis and demonstrates anti-fibrotic effects in the liver. Journal of Ethnopharmacology. 350. 120025–120025. 1 indexed citations
6.
Ma, Yuhui, Tian Tian, Shenglan Qi, et al.. (2025). Compound Yujie decoction ameliorates LPS-induced acute lung injury by suppressing NLRP3 inflammasome-mediated macrophage pyroptosis. Journal of Ethnopharmacology. 359. 121064–121064. 1 indexed citations
7.
Li, Yan, Fangyuan Wang, Guanghao Zhu, et al.. (2024). Bioactive components and mechanisms of Pu-erh tea in improving levodopa metabolism in rats through COMT inhibition. Food & Function. 15(10). 5287–5299. 4 indexed citations
8.
Shi, Xiaoli, Zhishen Xie, Hua Zhang, et al.. (2024). Isoastragaloside I attenuates cholestatic liver diseases by ameliorating liver injury, regulating bile acid metabolism and restoring intestinal barrier. Journal of Ethnopharmacology. 335. 118649–118649. 4 indexed citations
9.
Wang, Fangyuan, et al.. (2024). Multisubstrate‐based system: a kinetic mechanism study of catechol‐ O ‐methyltransferase. FEBS Journal. 292(4). 899–914. 1 indexed citations
10.
Wu, Jian, Yongbin Xu, Shenglan Qi, et al.. (2023). Extraction, characterization, and anti-nonalcoholic steatohepatitis activity of a (1,3) (1,6)-β-D-glucan from the Polyporus umbellatus (Pers.) Fries. International Journal of Biological Macromolecules. 230. 123252–123252. 11 indexed citations
11.
Qi, Shenglan, Zedong Xiang, Xin Sun, et al.. (2023). Ameliorative effect of scopolamine-induced cognitive dysfunction by Fufangmuniziqi formula: The roles of alkaloids, saponins, and flavonoids. Journal of Ethnopharmacology. 318(Pt A). 116792–116792. 8 indexed citations
12.
Xu, Feipeng, Hua Zhang, Jiamei Chen, et al.. (2023). Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease. Journal of Ethnopharmacology. 321. 117514–117514. 11 indexed citations
13.
Shen, Qin, Yadong Fu, Shenglan Qi, et al.. (2023). Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor. Journal of Ethnopharmacology. 318(Pt A). 116833–116833. 17 indexed citations
14.
Zhang, Feng, Tiantian Zhang, Shenglan Qi, et al.. (2022). The Chinese herb Styrax triggers pharmacokinetic herb-drug interactions via inhibiting intestinal CYP3A. Frontiers in Pharmacology. 13. 974578–974578. 8 indexed citations
16.
Zhu, Yudan, Wei Liu, Shenglan Qi, et al.. (2018). Stereoselective glucuronidation metabolism, pharmacokinetics, anti-amnesic pharmacodynamics, and toxic properties of vasicine enantiomers in vitro and in vivo. European Journal of Pharmaceutical Sciences. 123. 459–474. 13 indexed citations
17.
Qi, Shenglan, Huida Guan, Gang Deng, et al.. (2018). Rapid, reliable, and sensitive detection of adenosine deaminase activity by UHPLC-Q-Orbitrap HRMS and its application to inhibitory activity evaluation of traditional Chinese medicines. Journal of Pharmaceutical and Biomedical Analysis. 153. 175–181. 5 indexed citations
18.
Liu, Wei, Yudan Zhu, Yongli Wang, et al.. (2017). Anti-amnesic effect of extract and alkaloid fraction from aerial parts of Peganum harmala on scopolamine-induced memory deficits in mice. Journal of Ethnopharmacology. 204. 95–106. 29 indexed citations
19.
Li, Shuping, Yunpeng Zhang, Gang Deng, et al.. (2017). Exposure Characteristics of the Analogous β-Carboline Alkaloids Harmaline and Harmine Based on the Efflux Transporter of Multidrug Resistance Protein 2. Frontiers in Pharmacology. 8. 541–541. 18 indexed citations
20.
Liu, Wei, Xuemei Cheng, Yongli Wang, et al.. (2015). In vivo evaluation of the antitussive, expectorant and bronchodilating effects of extract and fractions from aerial parts of Peganum harmala linn. Journal of Ethnopharmacology. 162. 79–86. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026